ask="1.1500"
ask_size="2200"
average_daily_volume="678650"
bid="N/A"
bid_size="N/A"
book_value="0.6060"
change="-0.0022"
change_from_200_day_moving_average="-0.9630"
change_from_50_day_moving_average="-0.0501"
change_from_52_week_high="-3.9871"
change_From_52_week_low="0.4428"
change_in_percent="-0.2328%"
close="0.9428"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.2370"
ebitda="-8.78M"
eps_estimate_current_year="-1.1200"
eps_estimate_next_quarter="-0.2500"
eps_estimate_next_year="-0.3200"
ex_dividend_date="N/A"
float_shares="7029000"
high="0.9566"
high_52_weeks="4.9299"
last_trade_date="3/9/2017"
last_trade_price="0.9428"
last_trade_size="102"
last_trade_time="3:41pm"
low="0.9312"
low_52_weeks="0.5000"
market_capitalization="6.73M"
moving_average_200_day="1.9058"
moving_average_50_day="0.9929"
name="Opexa Therapeutics
Inc."
notes="N/A"
one_year_target_price="4.3300"
open="0.9590"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-50.5300%"
percent_change_from_50_day_moving_average="-5.0417%"
percent_change_from_52_week_high="-80.8759%"
percent_change_from_52_week_low="+88.5600%"
previous_close="0.9450"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.5594"
price_per_sales="2.6398"
revenue="2.56M"
shares_outstanding="7141000"
short_ratio="1.0600"
stock_exchange="NCM"
symbol="OPXA"
volume="38142"
weeks_range_52="0.5000 - 4.9299"
